Image
Practice Point
HER2 testing
Perform in situ hybridisation testing for HER2 status on core biopsy material if neoadjuvant systemic therapy is being considered, noting that receptor status between core and surgical specimens may be different.
How this guidance was developed
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process.
HER2 testing
Practice Point
Perform in situ hybridisation testing for HER2 status on core biopsy material if neoadjuvant systemic therapy is being considered, noting that receptor status between core and surgical specimens may be different.
Principles in action
Safe and quality care
No evidence-based source recommendation was identified for this topic, which was considered an important aspect of care. This practice point was developed using an expert consensus process.